These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 38729058

  • 1. Urinary soluble CD163 is a putative non-invasive biomarker for primary sclerosing cholangitis.
    Elger T, Fererberger T, Huss M, Sommersberger S, Mester P, Stoeckert P, Gunawan S, Liebisch G, Loibl J, Kandulski A, Müller M, Buechler C, Tews HC.
    Exp Mol Pathol; 2024 Jun; 137():104900. PubMed ID: 38729058
    [Abstract] [Full Text] [Related]

  • 2. Serum Galectin-3 as a Non-Invasive Marker for Primary Sclerosing Cholangitis.
    Bajraktari G, Elger T, Huss M, Loibl J, Albert A, Kandulski A, Müller M, Tews HC, Buechler C.
    Int J Mol Sci; 2024 Apr 27; 25(9):. PubMed ID: 38731984
    [Abstract] [Full Text] [Related]

  • 3. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis.
    Bossen L, Vesterhus M, Hov JR, Färkkilä M, Rosenberg WM, Møller HJ, Boberg KM, Karlsen TH, Grønbæk H.
    Clin Transl Gastroenterol; 2021 Mar 01; 12(3):e00315. PubMed ID: 33646203
    [Abstract] [Full Text] [Related]

  • 4. Symptoms Do Not Correlate With Findings From Colonoscopy in Children With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.
    Ricciuto A, Fish J, Carman N, Walters TD, Church PC, Hansen BE, Crowley E, Siddiqui I, Nguyen GC, Kamath BM, Griffiths AM.
    Clin Gastroenterol Hepatol; 2018 Jul 01; 16(7):1098-1105.e1. PubMed ID: 29378308
    [Abstract] [Full Text] [Related]

  • 5. Urinary and serum soluble CD25 complements urinary soluble CD163 to detect active renal anti-neutrophil cytoplasmic autoantibody-associated vasculitis: a cohort study.
    Dekkema GJ, Abdulahad WH, Bijma T, Moran SM, Ryan L, Little MA, Stegeman CA, Heeringa P, Sanders JF.
    Nephrol Dial Transplant; 2019 Feb 01; 34(2):234-242. PubMed ID: 29506265
    [Abstract] [Full Text] [Related]

  • 6. Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity.
    Tews HC, Elger T, Gunawan S, Fererberger T, Sommersberger S, Loibl J, Huss M, Liebisch G, Müller M, Kandulski A, Buechler C.
    Lipids Health Dis; 2023 Oct 03; 22(1):164. PubMed ID: 37789460
    [Abstract] [Full Text] [Related]

  • 7. Single-centre experience of the macrophage activation marker soluble (s)CD163 - associations with disease activity and treatment response in patients with autoimmune hepatitis.
    Grønbaek H, Kreutzfeldt M, Kazankov K, Jessen N, Sandahl T, Hamilton-Dutoit S, Vilstrup H, J Møller H.
    Aliment Pharmacol Ther; 2016 Nov 03; 44(10):1062-1070. PubMed ID: 27679428
    [Abstract] [Full Text] [Related]

  • 8. Calprotectin in bile: a disease severity marker in patients with primary sclerosing cholangitis.
    Voigtländer T, Wlecke J, Negm AA, Lenzen H, Manns MP, Lankisch TO.
    J Clin Gastroenterol; 2014 Nov 03; 48(10):866-9. PubMed ID: 24440929
    [Abstract] [Full Text] [Related]

  • 9. Urinary Soluble CD163 in Active Renal Vasculitis.
    O'Reilly VP, Wong L, Kennedy C, Elliot LA, O'Meachair S, Coughlan AM, O'Brien EC, Ryan MM, Sandoval D, Connolly E, Dekkema GJ, Lau J, Abdulahad WH, Sanders JS, Heeringa P, Buckley C, O'Brien C, Finn S, Cohen CD, Lindemeyer MT, Hickey FB, O'Hara PV, Feighery C, Moran SM, Mellotte G, Clarkson MR, Dorman AJ, Murray PT, Little MA.
    J Am Soc Nephrol; 2016 Sep 03; 27(9):2906-16. PubMed ID: 26940094
    [Abstract] [Full Text] [Related]

  • 10. Soluble CD163 as a Potential Biomarker in Systemic Sclerosis.
    Frantz C, Pezet S, Avouac J, Allanore Y.
    Dis Markers; 2018 Sep 03; 2018():8509583. PubMed ID: 29805720
    [Abstract] [Full Text] [Related]

  • 11. Usefulness of soluble CD163 as a biomarker for macrophage activation syndrome associated with systemic lupus erythematosus.
    Nishino A, Katsumata Y, Kawasumi H, Hirahara S, Kawaguchi Y, Yamanaka H.
    Lupus; 2019 Jul 03; 28(8):986-994. PubMed ID: 31246559
    [Abstract] [Full Text] [Related]

  • 12. Soluble PD1 levels are increased with disease activity in paediatric onset autoimmune hepatitis and inflammatory bowel disease.
    Hadley T, Gillespie S, Espinoza H, Prince J, Gronbaek H, Chandrakasan S, Kuguthasan S, Kolachala VL, Gupta NA.
    Autoimmunity; 2020 Aug 03; 53(5):253-260. PubMed ID: 32370568
    [Abstract] [Full Text] [Related]

  • 13. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
    Dige A, Støy S, Thomsen KL, Hvas CL, Agnholt J, Dahlerup JF, Møller HJ, Grønbaek H.
    Scand J Immunol; 2014 Dec 03; 80(6):417-23. PubMed ID: 25346048
    [Abstract] [Full Text] [Related]

  • 14. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
    Andersen MN, Abildgaard N, Maniecki MB, Møller HJ, Andersen NF.
    Eur J Haematol; 2014 Jul 03; 93(1):41-7. PubMed ID: 24612259
    [Abstract] [Full Text] [Related]

  • 15. Urinary Soluble CD163 Levels Predict IgA Nephropathy Remission Status.
    Gong S, Jin S, Li Y, Jiang W, Zhang Z, Shen Z, Wang J, Zhou H, Liu X, Xu X, Ding X, Shi Y, Liu H.
    Front Immunol; 2021 Jul 03; 12():769802. PubMed ID: 35003086
    [Abstract] [Full Text] [Related]

  • 16. Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panel.
    Stilund M, Gjelstrup MC, Petersen T, Møller HJ, Rasmussen PV, Christensen T.
    PLoS One; 2015 Jul 03; 10(4):e0119681. PubMed ID: 25860354
    [Abstract] [Full Text] [Related]

  • 17. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
    Peng QL, Zhang YL, Shu XM, Yang HB, Zhang L, Chen F, Lu X, Wang GC.
    J Rheumatol; 2015 Jun 03; 42(6):979-87. PubMed ID: 25877505
    [Abstract] [Full Text] [Related]

  • 18. Clinical significance of soluble CD163 in polymyositis-related or dermatomyositis-related interstitial lung disease.
    Enomoto Y, Suzuki Y, Hozumi H, Mori K, Kono M, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suzuki D, Ogawa N, Nakashima R, Mimori T, Iwashita T, Suda T.
    Arthritis Res Ther; 2017 Jan 19; 19(1):9. PubMed ID: 28103926
    [Abstract] [Full Text] [Related]

  • 19. Macrophage-related serum biomarkers soluble CD163 (sCD163) and soluble mannose receptor (sMR) to differentiate mild liver fibrosis from cirrhosis in patients with chronic hepatitis C: a pilot study.
    Andersen ES, Rødgaard-Hansen S, Moessner B, Christensen PB, Møller HJ, Weis N.
    Eur J Clin Microbiol Infect Dis; 2014 Jan 19; 33(1):117-22. PubMed ID: 24424890
    [Abstract] [Full Text] [Related]

  • 20. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
    Axelsson J, Møller HJ, Witasp A, Qureshi AR, Carrero JJ, Heimbürger O, Bárány P, Alvestrand A, Lindholm B, Moestrup SK, Stenvinkel P.
    Am J Kidney Dis; 2006 Dec 19; 48(6):916-25. PubMed ID: 17162146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.